Labyrinth Psychiatry Group

Labyrinth Psychiatry Group in Edison, New Jersey provides Spravato (esketamine), an FDA-approved nasal spray for adults with treatment-resistant depression and for depressive symptoms in adults with major depressive disorder and suicidal thoughts or actions. Made from ketamine, esketamine targets the glutamate system in the brain, offering rapid improvement for many patients who have not responded to traditional antidepressants.

Treatment involves inhaling three doses spaced five minutes apart under provider observation, followed by at least two hours of monitoring for side effects before discharge.

The licensed team carefully considers every treatment plan, recommending Spravato for adults over 18 who have tried at least two antidepressants without experiencing at least a 50% improvement. Telehealth appointments are available, and the practice integrates esketamine with conventional antidepressant care.